Moreover, MORC2 acetylation at K767, which is regulated by NAT10, promotes the transcription of cyclin-dependent kinase 1 and cyclin B1 to trigger the activation of the G2 checkpoint, which drives cell survival and progression of BC.27 This evidence concerns the gene MORC2 and breast cancer.